Dräger increases sales and earnings in the 2023 financial year - outlook for 2024 cautious.

Dräger increases sales and earnings in the 2023 financial year - outlook for 2024 cautious.

According to a report by www.hl-live.de, the 2023 financial year led to a significant increase in sales and earnings for Dräger. This is primarily due to the improved delivery capability and the high demand for Dräger products and services. Currency-adjusted sales rose by 13.2 percent to around 3,374 million euros. EBIT improved to 167 million euros, which corresponds to an EBIT margin of 4.9 percent. The equity ratio is well above average at over 40 percent.

These positive numbers could continue to impact the market and the financial industry. Due to the higher profitability and the strong equity ratio, Dräger intends to significantly increase the dividend and distribute around 30 percent of the consolidated net profit. This announcement could attract interest from investors and have an impact on Dräger's share price.

However, the forecast for 2024 envisages less strong growth, as the catch-up effects of previously limited delivery capacity will be missing in the current financial year. Dräger expects a currency-adjusted sales increase of 1.0 to 5.0 percent and an EBIT margin of 2.5 to 5.5 percent. This cautious forecast could lead to some reluctance among investors.

Overall, Dräger's preliminary figures for the 2023 financial year are extremely positive, but the cautious forecast for 2024 leaves room for further developments and possible effects on the market and the financial industry. It remains to be seen what the final business figures for 2023 and the full annual report will look like on March 7, 2024.